|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06990 SKB BIO-B
Nominal 
171.200 -1.300 (-0.754%) Ranking Overview
Ranking based on 9 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
9
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | -284.00 RMB (cts) | |
| Net Profit | -574.13 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | -229.60 | -104.00 | 0 | -- | 94.00 | -582.00 |
| 2025 | -869.00 | -396.30 | 0 | -- | -251.00 | -1,294.00 |
| 2026 | -512.50 | -224.40 | 0 | -- | 936.00 | -931.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | -226.00 | -101.00 | -- | CMB INT'L SEC | Buy | 243.38 | 21/08/2024 | |
| 2024 | -170.00 | -76.00 | -- | JP MORGAN | Overweight | 240.00 | 16/12/2024 | |
| 2024 | -582.00 | -261.00 | -- | HSBC | Buy | 237.00 | 29/11/2024 | |
| 2024 | 94.00 | 42.30 | -- | CLSA | OutPerform | 236.60 | 02/12/2024 | |
| 2024 | -489.00 | -220.00 | -- | CICC | OutPerform | 230.00 | 03/12/2024 | |
| 2024 | -278.00 | -125.00 | -- | UBS | Buy | 229.30 | 02/12/2024 | |
| 2024 | -427.39 | -192.00 | -- | HUATAI FIN HLDGS HK | Buy | 225.59 | 20/08/2024 | |
| 2024 | 66.00 | 30.10 | -- | CITIGROUP | Buy | 215.00 | 20/08/2024 | |
| 2024 | -229.60 | -104.00 | -- | HAITONG | OutPerform | 200.10 | 21/08/2024 | |
| 2025 | -964.00 | -432.00 | -- | CMB INT'L SEC | -- | -- | 21/08/2024 | |
| 2025 | -747.00 | -321.00 | -- | JP MORGAN | -- | -- | 16/12/2024 | |
| 2025 | -986.00 | -442.00 | -- | HSBC | -- | -- | 29/11/2024 | |
| 2025 | -251.00 | -112.80 | -- | CLSA | -- | -- | 02/12/2024 | |
| 2025 | -1,294.00 | -581.00 | -- | CICC | -- | -- | 03/12/2024 | |
| 2025 | -552.00 | -248.00 | -- | UBS | -- | -- | 02/12/2024 | |
| 2025 | -383.95 | -172.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 20/08/2024 | |
| 2025 | -869.00 | -396.30 | -- | CITIGROUP | -- | -- | 20/08/2024 | |
| 2025 | -1,013.22 | -460.00 | -- | HAITONG | -- | -- | 21/08/2024 | |
| 2026 | -931.00 | -418.00 | -- | CMB INT'L SEC | -- | -- | 21/08/2024 | |
| 2026 | -677.00 | -290.00 | -- | JP MORGAN | -- | -- | 16/12/2024 | |
| 2026 | -793.00 | -356.00 | -- | HSBC | -- | -- | 29/11/2024 | |
| 2026 | 936.00 | 420.00 | -- | CLSA | -- | -- | 02/12/2024 | |
| 2026 | -314.00 | -141.00 | -- | UBS | -- | -- | 02/12/2024 | |
| 2026 | 143.16 | 64.00 | -- | HUATAI FIN HLDGS HK | -- | -- | 20/08/2024 | |
| 2026 | -348.00 | -158.80 | -- | CITIGROUP | -- | -- | 20/08/2024 | |
| 2026 | -782.20 | -350.00 | -- | HAITONG | -- | -- | 21/08/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 24/12/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 310,226 |
| %Change | -- |
| EPS / (LPS) | RMB 1.410 |
| NBV Per Share (¥) | RMB 14.401 |